Bottom Article Ad

Monday, July 4, 2022

Global Epigenomics Market To be Driven by the Growing Need To Study Complex Diseases in the Forecast Period Of 2022-2027 

 The new report by Expert Market Research titled, ‘Global Epigenomics Market Report and Forecast 2022-2027’, gives an in-depth analysis of the global epigenomics market, assessing the market based on its segments like technology, product type, application, and major regions. The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.





Request a free sample copy in PDF or view the report summary@ https://www.expertmarketresearch.com/reports/epigenomics-market/requestsample

The key highlights of the report include:

Market Overview (2017-2027)

• Forecast CAGR (2022-2027): 13.1%

The increasing prevalence of cancer and other chronic diseases, along with the rising geriatric population, is poised to bolster the growth of the market globally. The presence of organisations such as the International Human Epigenome Consortium (IHEC) and the National Cancer Institute (NCI) is positively influencing the growth of the market. These organisations are promoting funding and support to research and development and product development exercises pertaining to the field of epigenetics. The market is majorly driven by the increasing prevalence of oncology, rising demand for early diagnostic procedures, and increasing usage of epigenetic biomarkers at various stages of cancer. Increasing usage of combination biomarkers and growing need for effective and early diagnostic procedures for cancer are some of the factors expected to augment the market growth at a significant rate.

Industry Definition and Major Segments

Epigenomics is the study of the epigenome, which is a collection of chemical molecules that direct the operation of the entire genome. These chemicals bind to DNA and activate or deactivate specific genes in the genome, altering its behaviour. As a result, the epigenome may alter protein production regulation in some body cells.

Explore the full report with the table of contents@ https://www.expertmarketresearch.com/reports/epigenomics-market

Based on technology, the global epigenomics market is segmented into:

• Histone Methylation
• Large Non-Coding RNA
• MicroRNA Modification
• DNA Methylation
• Chromatin Structures
• Others

By product type, the market is divided into:

• Kits
• Reagents
• Enzymes
• Others

The significant applications of the market are:

• Diagnostics
• Pharmaceuticals

On the basis of region, the market is segmented into:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Latest Global News on Epigenomics Market@  https://www.expertmarketresearch.com/pressrelease/global-epigenomics-market

Market Trends

Some of the factors driving the global market expansion include the government’s substantial funding for epigenetics research, the presence of enhanced healthcare facilities, and advances in diagnostic processes. Also, increased patient awareness of the availability of advanced products is another factor contributing to the market growth across the globe. There is a growing demand for cancer drugs in the United States, and numerous investments are being made in cancer genetics awareness, which is expected to accelerate the market’s expansion. The increased adoption of these treatment solutions coupled with rising investments in R&D activities and collaborations between pharmaceutical, biotechnology companies, and academic institutes will augment the statistics of the epigenomics market over the coming years.

Key Market Players

The major players in the market include Epigenomics AG, Illumina, Inc., Merck KGaA, Zymo Research Corporation, and Agilent Technologies, Inc., among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.

About Us:

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company’s expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Media Contact

Company Name: Claight Corporation
Contact Person: Ana John, Corporate Sales Specialist – U.S.A.
Email: sales@expertmarketresearch.com
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: https://www.expertmarketresearch.com

*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

0 Comments:

Post a Comment